Abstract 3093: Molecular profiling of tisotumab vedotin-treated patients identified immune pathways associated with clinical activity, supporting the multimodal mechanism of action
Year: 2025
Type: conference-abstract
Source: Cancer Research
Institution: Genmab (United States)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409690597
